Otto Simonsson
Researcher in Clinical Neuroscience at Karolinska Institute
Key Impact
Explores the psychiatric risks and benefits of psychedelic use, focusing on genetic and environmental factors.
Background & Research
Otto Simonsson is a Swedish researcher whose work examines the prevalence of mental health outcomes associated with naturalistic psychedelic use. He investigates how individual factors, such as a family history of mental illness, influence the response to psychedelics. His research aims to provide a more nuanced understanding of safety and risk profiles for psychedelic medicine in diverse populations.
Collaboration Network
41 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Substance Use Disorders (SUD)Depressive DisordersAnxiety DisordersImmunology & InflammationSafety & Risk ManagementAdolescentsOlder AdultsInterpersonal Functioning & Social ConnectednessPersonality & Trait FactorsBipolar DisorderSchizophreniaTobacco/Nicotine Use Disorder (TUD)Set & SettingPublic Health, Prevention & Behaviour ChangeNeuroimaging & Brain MeasuresTreatment-Resistant Depression (TRD)Implementation & Service DeliverySuicidalityPTSDPalliative & End-of-Life DistressNeurocognitive Disorders